ONGUENT SAPIN FORTIN
Natural health product licensed in Canada
- Licence holder
- 9248-8014 Québec Inc.
- NPN or DIN-HM
- 80043490
- Status
- Active licence
- Licence date
- 10 July 2013
- Revision date
- Not provided
- Form
- Onguent
- Route of administration
- Topique
- Application type
- Officinale
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| dl-Menthol Source : dl-Menthol | 2.6 % |
| Eucalyptus globulus Source : Eucalyptus | 1.2 % |
| Eucalyptus globulus Source : Feuille | 1.2 % |
| dl-Camphre Source : dl-Camphre | 4.7 % |
Non-medicinal ingredients
Huile essentielle de thym, Pétrolatum, Huile essentielle d'aiguilles de sapin baumier
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes, adolescents et enfants | minimum: 2 years | Not specified | Not specified |
Uses authorised in Canada
Soulage temporairement la douleur et les courbatures des muscles et des articulations associée(s) au mal de dos, lumbago, contusions, foulure/entorse et la douleur arthritique.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Garder hors de portée des enfants. En cas de surdosage ou d'ingestion accidentelle, appeler un Centre Antipoison immédiatement. Cesser l'utilisation et consulter un praticien de soins de santé si les symptômes persistent et/ou s'aggravent après 7 jours ou si les symptômes reviennent après quelques jours. Consulter un praticien de soins de santé avant d'en faire l'usage si vous êtes enceinte ou si vous allaitez.
Source
Official Health Canada record, licence 80043490
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.